Literature DB >> 2421035

Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients.

H Tomoda, M Furusawa.   

Abstract

The significance of measurement of serum CA 19-9 levels and the correlation between the serum levels of CA 19-9 and CEA in 61 patients with colorectal cancer were investigated. CA 19-9 levels above 37 U/ml were found in 24.6 per cent, while CEA levels above 5 ng/ml were observed in 34.4 per cent. Elevation of one or both of two antigens was found in 44.3 per cent. In patients with elevated CA 19-9 levels, the CA 19-9 levels returned to normal after curative resections, whereas patients with normal levels of this antigen showed only slight or no differences after curative resections. Measurements of this antigen were useful for the evaluation of the effect of surgery, especially in patients with normal CEA levels and elevated CA 19-9 levels. Combination assays of these antigens may be more useful than CEA alone for monitoring colorectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421035     DOI: 10.1007/bf02471074

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  5 in total

1.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

2.  Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer.

Authors:  H F Sears; M Herlyn; B Del Villano; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

3.  Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma.

Authors:  M Herlyn; H F Sears; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

4.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Authors:  B C Del Villano; S Brennan; P Brock; C Bucher; V Liu; M McClure; B Rake; S Space; B Westrick; H Schoemaker; V R Zurawski
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

5.  Gastrointestinal cancer-associated antigen in immunoperoxidase assay.

Authors:  B F Atkinson; C S Ernst; M Herlyn; Z Steplewski; H F Sears; H Koprowski
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.